Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery
Launched by KONKUK UNIVERSITY MEDICAL CENTER · Nov 16, 2023
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different treatments to help manage bleeding during heart surgery, specifically for patients with heart valve disease. The researchers want to compare how quickly they can stop bleeding when using either Fresh Frozen Plasma (FFP) or Prothrombin Complex Concentrate (PCC), which are both products that help with blood clotting. This study is important for ensuring that patients receive the best possible care during surgery.
To participate in this trial, you need to be someone who is scheduled for cardiac surgery. However, if you have low platelet counts, are taking blood-thinning medications, or using anti-platelet drugs, you won’t be eligible to join. If you do qualify, you can expect to be part of a study that aims to improve bleeding management during surgery, which could lead to better outcomes for patients in the future. The trial is not yet recruiting participants, but it’s a step towards finding the most effective ways to handle bleeding during heart procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients undergoing cardiac surgery
- Exclusion Criteria:
- • thrombocytopenia
- • oral anti-coagulant
- • anti platelet agents
About Konkuk University Medical Center
Konkuk University Medical Center is a leading healthcare institution located in Seoul, South Korea, recognized for its commitment to advancing medical research and improving patient care. As a clinical trial sponsor, the center leverages its state-of-the-art facilities and multidisciplinary expertise to conduct innovative research that addresses critical health challenges. With a focus on collaboration and ethical standards, Konkuk University Medical Center aims to contribute significantly to the development of new treatments and therapies, enhancing the overall quality of healthcare both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Tae-Yop Kim, MD PhD
Principal Investigator
Konkuk University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported